Gonadotropin-dependent precocious puberty in a female offspring who is a potential carrier for BRCA2 pathogenic variant: An additional consideration for gonadotropin-releasing hormone agonist treatment.

Tsuura, Kairi; Sato, Takeshi; Nakano, Satsuki; Ishii, Tomohiro; Hasegawa, Tomonobu

Tsuura, Kairi; Sato, Takeshi; Nakano, Satsuki; Ishii, Tomohiro; Hasegawa, Tomonobu.

Affiliation

Tsuura K; Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
Sato T; Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
Nakano S; Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
Ishii T; Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
Hasegawa T; Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.

Pediatr Blood Cancer ; 70(6): e30265, 2023 06.

Article in En | MEDLINE | ID: mdl-36815581

Subject(s)

Puberty, Precocious; Female; Humans; Body Height; BRCA2 Protein; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Puberty, Precocious/pathology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Puberty, Precocious Limits: Female / Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2023 Document type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google